全国队列中宫颈癌筛查不足、过度筛查及指南依从性筛查情况
基于MarketScan行政数据库纳入2015—2019年连续参保6年的21—65岁女性1,872,809例,其中1,471,063例(78.5%)符合常规筛查条件;该人群中仅18.1%接受指南依从性筛查,25.4%在6年内未筛查,年轻女性更易过度筛查(OR 1.46),年长女性更易筛查不足或未筛查(OR 2.54)。
要点
- 符合常规筛查条件的女性中仅18.1%接受指南依从性筛查,25.4%在6年内未筛查。
- 21—39岁女性更易过度筛查(OR 1.46),50—64岁女性更易筛查不足或未筛查(OR 2.54)。
- 指南依从性筛查率以单独HPV检测最高(80%),联合检测次之(44%),单独细胞学最低(15%)。
核心结论
- 筛查不足与过度筛查均处于高水平,提示需要额外策略以改善指南依从性诊疗。
研究设计与样本
- 查询MarketScan数据库(全国性雇员保险行政数据库)中2015—2019年连续参保6年的21—65岁女性中与宫颈癌筛查相关的要素。
- 平均风险女性定义为无高危医疗状况或异常筛查史,且无因良性指征行子宫切除并切除宫颈的证据。
- 平均风险女性接受单独Pap检测间隔2.5—3.5年,或HPV检测或联合检测间隔4.5—5.5年,视为充分筛查。
- 采用逻辑回归预测接受指南依从性筛查、筛查不足和过度筛查的比值比。
主要发现
- 1,872,809例合格患者中1,471,063例(78.5%)符合常规筛查条件。
- 符合常规筛查条件者中仅18.1%接受指南依从性筛查,25.4%在6年期间未筛查。
- 年轻女性(21—39岁)更易过度筛查(OR 1.46)。
- 年长女性(50—64岁)在研究期间更易筛查不足或未筛查(OR 2.54)。
- 指南依从性筛查率以单独HPV检测最高(80%),联合检测次之(44%),单独细胞学最低(15%)。
关键数值与推荐
- 平均风险女性充分筛查标准:单独Pap检测间隔2.5—3.5年,或HPV检测或联合检测间隔4.5—5.5年。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore rates of under- and overscreening for cervical cancer among a national cohort. METHODS: The MarketScan database, a national administrative database of employee-sponsored insurance, was queried for elements relevant to cervical cancer screening among women aged 21-65 with 6 years of continuous enrollment (2015-2019). Average-risk women were defined as those without high-risk medical conditions or abnormal screening histories, and without evidence of hysterectomy with removal of the cervix for benign indications. Average-risk women were considered adequately screened if they had Pap tests alone at 2.5-3.5 year intervals, or HPV tests or co-tests at 4.5-5.5 year intervals. Logistic regressions were used to predict the odds of receiving guideline-adherent screening, underscreening, and overscreening. RESULTS: Among 1,872,809 eligible patients, 1,471,063 (78.5%) qualified for routine screening. Of these, only 18.1% received guideline-adherent screening, and 25.4% were unscreened during the 6-year period. Younger women (aged 21-39) were more likely to be overscreened [OR 1.46]. Older women (aged 50-64) were more likely to be underscreened or unscreened during the study period [OR 2.54]. Guideline-adherent screening was highest with HPV testing alone (80%) followed by co-testing (44%), and lowest with cytology alone (15%). A total of 329,062 women in this general population sample (18%) met high-risk criteria that required increased frequency of screening. CONCLUSIONS: High rates of both underscreening and overscreening indicate a need for additional strategies to improve guideline-adherent care. CLINICAL TRIAL REGISTRATION: N/A.
引用
- Lee YW, Morgan JR, Fiascone S, et al. Underscreening, overscreening, and guideline-adherent cervical cancer screening in a national cohort. Gynecol Oncol. 2022. PMID: 36150914. doi:10.1016/j.ygyno.2022.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。